Dalmia Cement (Bharat) Ltd (DCBL) has agreed to sell its entire investment of 18,723,743 equity shares in Dalmia Bharat Refractories Ltd to M/s Sarvapriya Healthcare Solutions Private Ltd. The transaction represents 42.36 per cent of share capital, at a total consideration of INR8000m (US$97.12m), and forms part of DCBL’s strategy to exit non-core business/investment, according to the company.

Cemento Polpaico reports CLP259m net profit for 2024
Chile based Cemento Polpaico posted a 0.4 per cent drop in revenues to CLP339.908bn (US$359.8m...